Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 25 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Bakirtzis, Christos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Bakirtzis, C., Koutroulou I., Nikolaidis I., Karapanayiotides T., & Grigoriadis N. (2019).  "Radiologically Isolated" Spinal Cavernoma Associated with Familial Cerebral Cavernomatosis.. Eur Neurol. 81(5-6), 327-330.
Bakirtzis, C., Ioannidis P., Messinis L., Nasios G., Konstantinopoulou E., Papathanasopoulos P., et al. (2018).  The Rationale for Monitoring Cognitive Function in Multiple Sclerosis: Practical Issues for Clinicians.. Open Neurol J. 12, 31-40.
Boziki, M. Kleopatra, Karapanayotides T., Papadopoulos G., Lagoudaki R., Melo P., Bakirtzis C., et al. (2020).  Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk. Neurological Research. 42811574(3133), 209 - 221.
Boziki, M. Kleopatra, Karapanayotides T., Papadopoulos G., Lagoudaki R., Melo P., Bakirtzis C., et al. (2020).  Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.. Neurol Res. 42(3), 209-221.
Printza, A., Kalaitzi M., Bakirtzis C., Nikolaidis I., Proios H., & Grigoriadis N. (2018).  Reliability and validity of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis (Greek version) and proposed modification.. Mult Scler Relat Disord. 23, 62-68.
Artemiadis, A., Bakirtzis C., Ifantopoulou P., Zis P., Bargiotas P., Grigoriadis N., et al. (2020).  The role of cognitive reserve in multiple sclerosis: A cross-sectional study in 526 patients.. Mult Scler Relat Disord. 41, 102047.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.